Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Marcor Development is a U.S.-based specialty distributor of chemicals and naturally derived ingredients serving pharmaceutical, nutraceutical, biological, microbiology, fermentation, diagnostic media, and related health markets. Historically headquartered in Carlstadt, New Jersey, the company focused on value-added distribution rather than proprietary drug development. Marcor was acquired by KODA Distribution Group on January 10, 2014, and KODA was subsequently acquired by Azelis, after which Marcor was integrated into Azelis Americas' pharma and healthcare activities. The business appears to persist primarily as a legacy brand/domain within Azelis Pharma & Healthcare rather than as a standalone biotech company with its own therapeutic pipeline. Its role is commercial supply, technical support, and ingredient distribution for healthcare and life-science manufacturers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Marcor Development.